No standalone federal psychedelic rescheduling bill is enacted in 2026; advancement flows only through appropriations/veteran research provisions.
Predicted 2026-07-13 · Resolves 2027-01-09 · legislation · USA
There is a real difference between Congress paying for research (tucking a line item into a big spending bill) and Congress actually changing drug law (passing a standalone bill). In 2026, the most likely path is veterans' research funding slipped into a larger budget package — not a dedicated new law rescheduling or legalizing any psychedelic. That means progress, but not the kind that changes what's legal.
Resolution rule: YES if, by 2027-01-09, no standalone bill whose primary purpose is rescheduling a psychedelic substance has been signed into law during 2026 (appropriations riders do not count as standalone). Check congress.gov for enacted public laws (search 'psilocybin', 'MDMA', 'psychedelic'). NO if such a standalone law is enacted. Check date: 2027-01-09.
Standalone reform lacks floor votes; the achievable vehicle is appropriations riders funding VA/DoD research. Congress funds study, not access.